Share
662 Posts.
lightbulb Created with Sketch. 332
clock Created with Sketch.
23/10/19
12:24
Share
Originally posted by Galilee13:
↑
did everyone just read the GMV response to the ASX query letter only? If not I suggest everyone read the letter the ASX sent GMV on October 16, which required a response by October 23, which GMV sent the ASX on October 21. This in itself shows GMV is serious and not stuffing anyone around. The letter sent by the ASX is basically a summary of its findings after the first ASX query. It's provides some great insights into the MOUs and Hygea deal. The market rightly is moving the share price up. Based on these extensive and detailed responses to the NMPA approval process, GMV are very confident of receiving approval for the prizma over the next 9 months. This will then trigger the MOUs and significant revenue. The ASX gave GMV every opportunity to can the Hygea deal, but they didn't, they still expect the deal to go ahead. Question is when. I'm expecting positive things from the 4c and company update next week. $2m in revenue is highly possible. An update on UK contracts is almost certain. HK IPO still targeting the next 6 mths? Let's not forget the US business. Huge infrastructure in place in monitoring centres and sales staff ready to roll out the prizma and patch to an existing market as soon as approvals are received. With the company doing around $12m AUD a year in revenue and approvals due in less than 12 mths we are still trading sub $50m AUD market cap. It should be more IMO.
Expand
Hi Galilee, Not sure 12m revenue is correct - I think it's closer to 8m AU. I'm not expecting anything great from the next 4c. I think that revenue will be stuck at around 1.5m US for the quarter. I don't expect to hear anything about the UK as the company has gone silent on that lately. With GMV, it is always best to look at the worst case scenario, that way, anything on top of that is a bonus. I still hold a little bit of hope that the company can turn around when it gets NMPA.